Clinical trial
Lactobacillus Rhamnosus in Prevention of Chemotherapy-related Diarrhoea
NCT00197873 · University of Helsinki, Other · Completed
Key facts
| NCT number | NCT00197873 |
|---|---|
| Title | Lactobacillus Rhamnosus in Prevention of Chemotherapy-related Diarrhoea |
| Official title | Randomized, Double Blind, Placebo Controlled, Cross-over Phase II Study on the Effects of Lactobacillus Rhamnosus GG Supplementation in Patients on 1st Line XELOXA Treatment for Metastatic Colorectal Cancer |
| Lead sponsor | University of Helsinki, Other |
| Collaborators | Helsinki University Central Hospital |
| Status | Completed |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Dietary Supplement, Other |
| Interventions | Lactobacillus Rhamnosus supplementation, Placebo administration. |
| Enrollment | 84 |
| Start date | Sep 1, 2005 |
| Primary completion | Nov 30, 2020 |
| Completion | Dec 31, 2020 |
| First posted | Sep 20, 2005 |
| Last update posted | Nov 24, 2021 |
| Countries | Finland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: